Food and Drug Administration (FDA)

fast speed night U-turn drive overpass
Biotech

With FDA rejection for eye drug, Aldeyra plans speedy new trial

Aldeyra Therapeutics had prepared for the worst and now it's here. The FDA has rejected the dry eye drug reproxalap.
Annalee Armstrong Nov 28, 2023 4:30am
FDA stop sign

FDA rebuffs Entrada's attempt to get DMD clinical hold lifted

Nov 22, 2023 9:25am
binoculars path forward advance see look

Inovio drafts accelerated approval talking points for FDA visit

Nov 10, 2023 7:28am
FDA stop sign

Nurix's cancer drug on partial hold while manufacturing upgraded

Nov 2, 2023 8:40am
Image of a crossing guard sign in the foreground with a crossing guard directing traffic in the background

FDA advisers wave through first CRISPR-based therapy

Nov 1, 2023 11:07am
An arrow incrementally going up stairs before pointing straight up Blue background

Deciphera's tumor-tackling oral med achieves 40% response rate

Oct 30, 2023 11:00am